Results 101 to 110 of about 2,693 (166)

Drug-Drug Interactions in Recently Approved Antibacterials: A Mini Review. [PDF]

Eur J Drug Metab Pharmacokinet
Baccari I, Bergmann F, Zeitlinger M.
europepmc   +1 more source

Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactams. [PDF]

Antimicrob Agents Chemother
Dorazio AJ, Kline EG, Squires KM, Shah S, Van Tyne D, Wu JY, Pogue JM, Shields RK.   +7 more
europepmc   +1 more source

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study. [PDF]

Antimicrob Agents Chemother
Gottesdiener LS, Li Y, Greenwood-Quaintance KE, Komarow L, Arias CA, Cober E, Herc ES, Kaye KS, Huskins WC, Figueroa J, Vilchez S, Fries BC, Leroi M, McCarty TP, Rioseco ML, Munita JM, Stryjewski ME, Reyes J, Chen L, Kreiswirth BN, Hill C, Baum K, Villegas MV, Paterson DL, Bonomo RA, Chambers HF, Fowler VG, Patel R, Doi Y, van Duin D, Satlin MJ, Antibacterial Resistance Leadership Group.   +31 more
europepmc   +1 more source

From bugs to bots: learning infectious diseases in the AI era. [PDF]

Antimicrob Steward Healthc Epidemiol
Rodriguez-Nava G.
europepmc   +1 more source

Phenotypic profile and molecular mechanism of resistance in carbapenemase-producing Enterobacterales and <i>Pseudomonas aeruginosa</i> isolates from Brazilian hospitals: implications for the introduction of imipenem-relebactam. [PDF]

Front Microbiol
Kurtz P, Del Peloso PF, Pribul BR, Albuquerque AM, Antunes BBP, Ramos GV, Bozza FA.   +6 more
europepmc   +1 more source

Spread of carbapenemase-producing <i>Serratia</i> spp. in France from 2016 to 2024: a comparative genomic study. [PDF]

Emerg Microbes Infect
Rezzoug I, Bernabeu S, Ouacel K, Birer A, Jousset AB, Larouy-Maumus G, Bonnin RA, Emeraud C, Dortet L.   +8 more
europepmc   +1 more source

Optimizing target inactivation to treat multidrug-resistant <i>Escherichia coli</i> with NDM and PBP3 mutations: "going the extra mile". [PDF]

Antimicrob Agents Chemother
Fabrizio C, Valzano F, Giuliano S, Morelli E, Serio D, Buccoliero GB, Cervellera M, La Bella G, Arena F, Hujer AM, Taracila MA, Marshall SH, Bonomo RA, Tascini C.   +13 more
europepmc   +1 more source

Classification and applicability of new beta-lactamase inhibitors. [PDF]

Rev Esp Quimioter
Cercenado E, Candel FJ.
europepmc   +1 more source

Insights into <i>Klebsiella pneumoniae</i> carbapenem resistance-a two-year retrospective study from a Romanian tertiary care hospital. [PDF]

Front Microbiol
Tălăpan D, Dan MO, Cireşă A, Rafila A.   +3 more
europepmc   +1 more source

Current progress in antibacterial agents for carbapenem-resistant enterobacterales. [PDF]

Front Pharmacol
Xu W, Shang L, Li X, Yu J, Shen J, Li Y, He Q, Chen L, Wang D, Wei Y, Niu S.   +10 more
europepmc   +1 more source